News
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020
PORTLAND, Maine, Jan. 07, 2021 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Restructuring of its Bank Debt
PORTLAND, Maine, Dec. 15, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020
PORTLAND, Maine, Nov. 12, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020
Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ETPORTLAND, Maine, Nov. 05, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020
PORTLAND, Maine, Oct. 06, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020
PORTLAND, Maine, Aug. 12, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
PORTLAND, Maine, July 07, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Receives $500,000 Loan from the Maine Technology
PORTLAND, Maine, June 16, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference
On Tuesday, May 20th at 11:00 am ETPORTLAND, Maine, May 14, 2020 -- ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...